Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels

References

• Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol. 2013;24:1434–1443.
   PubMed Web of Science ®Google Scholar
• van Wely BJ, de Wilt JHW, Francissen C, et al. Meta-analysis of ultrasound-guided biopsy of suspicious axillary lymph nodes in the selection of patients with extensive axillary tumour burden in breast cancer. Br J Surg. 2015; 102:159–168.
   PubMed Web of Science ®Google Scholar
• Majzoub RN, Chan CL, Ewert KK, et al. Uptake and transfection efficiency of PEGylated cationic liposome–DNA complexes with and without RGD-tagging. Biomaterials. 2014;35:4996–5005.
   PubMed Web of Science ®Google Scholar
• Shi JF, Sun MG, Li XY, et al. A combination of targeted sunitinib liposomes and targeted vinorelbine liposomes for treating invasive breast cancer. J Biomed Nanotechnol. 2015;11:1568–1582.
   PubMed Web of Science ®Google Scholar
• Vo DT, Sabrina S, Lee CK. Silver deposited carboxymethyl chitosan-grafted magnetic nanoparticles as dual action deliverable antimicrobial materials. Mat Sci Eng C-Mater. 2017;73:544–551.
   Google Scholar
• Li J, Guo Y. Basic evaluation of typical nanoporous silica nanoparticles in being drug carrier: structure, wettability and hemolysis. Mat Sci Eng C-Mater. 2017;73: 670–673.
   Google Scholar
• Volsi AL, Aberasturi DJ, Lacey MH, et al. Inulin coated plasmonic gold nanoparticles as a tumor-selective tool for cancer therapy. J Mater Chem B. 2016;4:1150–1155.
   PubMed Web of Science ®Google Scholar
• Yang JP, Liao YD, Mai DM, et al. Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis. Angiogenesis. 2016;19:191–200.
   PubMed Web of Science ®Google Scholar
• Liu W, Meng M, Zhang B, et al. Dehydroeffusol effectively inhibits human gastric cancer cell-mediated vasculogenic mimicry with low toxicity. Toxicol Appl Pharm. 2015; 287:98–110.
   PubMed Web of Science ®Google Scholar
• Ju RJ, Zeng F, Liu L, et al. Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma. Int J Nanomed. 2016;11:1131–1146.
   PubMed Web of Science ®Google Scholar
• Eloy JO, Souza MC, Petrilli R, et al. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery. Colloid Surface B. 2014; 123:345–363.
   PubMed Web of Science ®Google Scholar
• Liu YP, Gao DW, Zhang XW, et al. Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes. Mater Sci Eng C-Mater. 2016;64:124–132.
   PubMed Web of Science ®Google Scholar
• Wheaten SA, Ablan FD, Spaller BL, et al. Translocation of cationic amphipathic peptides across the membranes of pure phospholipid giant vesicles. J Am Chem Soc. 2013;135:16517–16525.
   PubMed Web of Science ®Google Scholar
• Liu JL, Ma QP, Huang QD, et al. Cationic lipids containing protonated cyclen and different hydrophobic groups linked by uracil-PNA monomer: synthesis and application for gene delivery. Eur J Med Chem. 2011;46:4133–4141.
   PubMed Web of Science ®Google Scholar
• Fan Y, Sahdev P, Ochyl LJ, et al. Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens. J Control Release. 2015;208:121–129.
   PubMed Web of Science ®Google Scholar
• Xiong QQ, Cui MM, Bai Y, et al. A supramolecular nanoparticle system based on beta-cyclodextrin-conjugated poly-l lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma. Colloid Surf B. 2017;155:93–103.
   PubMed Web of Science ®Google Scholar
• Lee J, Yoo KC, Ko J, et al. Hollow hyaluronic acid particles by competition between adhesive and cohesive properties of catechol for anticancer drug carrier. Carbohydr Polym. 2017;164:309–316.
   PubMed Web of Science ®Google Scholar
• Wang N, Wang ZH, Nie SH, et al. Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo. IJN. 2017;12:1499–1514.
   Google Scholar
• Zhang YX, Chen T, Yuan P, et al. Encapsulation of honokiol into self-assembled pectin nanoparticles for drug delivery to HepG2 cells. Carbohydr Polym. 2015;133:31–38.
   PubMed Web of Science ®Google Scholar
• Zhang YB, Ren X, Shi MY, et al. Downregulation of STAT3 and activation of MAPK are involved in the induction of apoptosis by HNK in glioblastoma cell line U87. Oncol Rep. 2014;32:2038–2046.
   PubMed Web of Science ®Google Scholar
• Liu FR, Jin H, Wang Y, et al. Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia. Drug Deliv. 2017;24:882–890.
   PubMed Web of Science ®Google Scholar
• Metaxa AF, Efthimiadou EK, Boukos N, et al. Hollow microspheres based on – folic acid modified – hydroxypropyl cellulose and synthetic multi-responsive bio-copolymer for targeted cancer therapy: controlled release of daunorubicin, in vitro and in vivo studies. J Colloid Interface Sci. 2014;435:171–181.
   PubMed Web of Science ®Google Scholar
• Alonso SL, Longo G, Dietler G, et al. Time-lapse AFM imaging of DNA conformational changes induced by daunorubicin. Nano Lett. 2013;13:5679–5684.
   PubMed Web of Science ®Google Scholar
• Li XT, He ML, Zhou ZY, et al. The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: in vitro and in vivo evaluation. Int J Pharm. 2015;487:223–233.
   PubMed Web of Science ®Google Scholar
• Song XL, Liu S, Jiang Y, et al. Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma. Eur J Pharm Sci. 2017; 96:129–140.
   PubMed Web of Science ®Google Scholar
• Li XT, Zhou ZY, Jiang Y, et al. PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer. J Drug Target. 2015;23:232–243.
   PubMed Web of Science ®Google Scholar
• Ju RJ, Li XT, Shi JF, et al. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer. Biomaterials. 2014;35:7610–7621.
   PubMed Web of Science ®Google Scholar
• Ying X, Wen H, Lu WL, et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release. 2010;141:183–192.
   PubMed Web of Science ®Google Scholar
• Duncan GA, Bevan MA. Computational design of nanoparticle drug delivery systems for selective targeting. Nanoscale. 2015;7:15332–15340.
   PubMed Web of Science ®Google Scholar
• Sakurai Y, Hada T, Yamamoto S, et al. Remodeling of the extracellular matrix by endothelial cell-targeting siRNA improves the EPR-based delivery of 100 nm particles. Mol Ther. 2016;24:2090–2099.
   PubMed Web of Science ®Google Scholar
• Wei HL, Wang FH, Wang Y, et al. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex. Cancer Sci. 2017;108:478–487.
   PubMed Web of Science ®Google Scholar
• Kato S, Kimura M, Miwa N. Enhanced radiosensitization by the cationic liposome-encapsulated thymidine analogue BrdU through the increased intracellular BrdU-uptake on human melanoma as compared to anionic or nonionic liposomal or free BrdU. J Biomed Nanotechnol. 2014;10: 3280–3290.
   PubMed Web of Science ®Google Scholar
• Liu TJ, Sun BC, Zhao XL, et al. USP44+ cancer stem cell subclones contribute to breast cancer aggressiveness by promoting vasculogenic mimicry. Mol Cancer Ther. 2015;14:2121–2131.
   PubMed Web of Science ®Google Scholar
• Gu WD, Zhang XC, Gong B, et al. VMCast: a VM-assisted stability enhancing solution for tree-based overlay multicast. PLoS One. 2015;10:e0142888.
   PubMed Web of Science ®Google Scholar
• Ren K, Yao N, Wang GY, et al. Vasculogenic mimicry: a new prognostic sign of human osteosarcoma. Hum Pathol. 2014;45:2120–2129.
   PubMed Web of Science ®Google Scholar
• Kallel MH, Jan SL, Bernard P, et al. Histone deacetylases meet microRNA-associated MMP-9 expression regulation in glucocorticoid-sensitive and -resistant cell lines. Int J Oncol. 2017;50:717–726.
   PubMed Web of Science ®Google Scholar
• Her Z, Kam YW, Gan VC, et al. Severity of plasma leakage is associated with high levels of interferon gamma-inducible protein 10, hepatocyte growth factor, matrix metalloproteinase 2 (MMP-2), and MMP-9 during dengue virus infection. J Infect Dis. 2017;215:42–51.
   PubMed Web of Science ®Google Scholar